Miloš Jeseňák

3.3k total citations
119 papers, 1.6k citations indexed

About

Miloš Jeseňák is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Miloš Jeseňák has authored 119 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Physiology, 33 papers in Pulmonary and Respiratory Medicine and 21 papers in Immunology. Recurrent topics in Miloš Jeseňák's work include Asthma and respiratory diseases (32 papers), Pediatric health and respiratory diseases (16 papers) and Allergic Rhinitis and Sensitization (14 papers). Miloš Jeseňák is often cited by papers focused on Asthma and respiratory diseases (32 papers), Pediatric health and respiratory diseases (16 papers) and Allergic Rhinitis and Sensitization (14 papers). Miloš Jeseňák collaborates with scholars based in Slovakia, Czechia and Sweden. Miloš Jeseňák's co-authors include Peter Bánovčin, Juraj Majtán, Eva Babušíková, Zuzana Rennerová, Zuzana Diamant, Dušan Dobrota, Ingrid Urbančíková, M Hrubiško, Anna Bobčáková and Ján Kyselovič and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and CHEST Journal.

In The Last Decade

Miloš Jeseňák

111 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miloš Jeseňák Slovakia 21 312 278 272 245 201 119 1.6k
Tobias Polte Germany 27 425 1.4× 153 0.6× 762 2.8× 448 1.8× 200 1.0× 43 2.1k
Roberto Silva Costa Brazil 28 123 0.4× 287 1.0× 405 1.5× 336 1.4× 83 0.4× 122 2.3k
Ivana Čepelak Croatia 22 316 1.0× 350 1.3× 449 1.7× 155 0.6× 58 0.3× 90 1.7k
Suck Chei Choi South Korea 28 246 0.8× 323 1.2× 531 2.0× 259 1.1× 63 0.3× 147 2.4k
Antônio Carlos Seguro Brazil 28 184 0.6× 305 1.1× 512 1.9× 110 0.4× 154 0.8× 117 2.3k
Mohammad Najafi Iran 23 164 0.5× 136 0.5× 568 2.1× 179 0.7× 68 0.3× 166 1.8k
Junpeng Wang China 28 190 0.6× 285 1.0× 819 3.0× 648 2.6× 109 0.5× 102 2.7k
Wim Calame Netherlands 22 230 0.7× 138 0.5× 395 1.5× 370 1.5× 97 0.5× 57 2.0k
Lúcia Andrade Brazil 31 186 0.6× 327 1.2× 528 1.9× 126 0.5× 278 1.4× 102 2.5k
David Lamb United Kingdom 24 211 0.7× 199 0.7× 340 1.3× 337 1.4× 121 0.6× 70 1.6k

Countries citing papers authored by Miloš Jeseňák

Since Specialization
Citations

This map shows the geographic impact of Miloš Jeseňák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloš Jeseňák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloš Jeseňák more than expected).

Fields of papers citing papers by Miloš Jeseňák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miloš Jeseňák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloš Jeseňák. The network helps show where Miloš Jeseňák may publish in the future.

Co-authorship network of co-authors of Miloš Jeseňák

This figure shows the co-authorship network connecting the top 25 collaborators of Miloš Jeseňák. A scholar is included among the top collaborators of Miloš Jeseňák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miloš Jeseňák. Miloš Jeseňák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diamant, Zuzana, et al.. (2025). Effect of a Pleuran-Based Supplement on Salivary IgA Secretion in Children With Recurrent Respiratory Infections. Current Therapeutic Research. 102. 100780–100780.
2.
Bobčáková, Anna, et al.. (2025). Is Canakinumab Safe During Pregnancy? New Insights from Three Cases in Slovakia. SHILAP Revista de lepidopterología. 5(2). 12–12. 1 indexed citations
3.
Bobčáková, Anna, et al.. (2024). Association Between Cytometric Biomarkers, Clinical Phenotype, and Complications of Common Variable Immunodeficiency. Cureus. 16(1). e52941–e52941. 1 indexed citations
4.
Čižnár, Peter, Marion Roderick, Miloš Jeseňák, et al.. (2024). fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study. Allergy Asthma and Clinical Immunology. 20(1). 47–47. 1 indexed citations
5.
Conti, Diego M., Vibeke Backer, Leif Bjermer, et al.. (2024). EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus. Pediatric Allergy and Immunology. 35(7).
6.
Rogers, Linda, Miloš Jeseňák, Leif Bjermer, et al.. (2023). Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient. Respiratory Medicine. 218. 107414–107414. 28 indexed citations
7.
Jeseňák, Miloš, et al.. (2023). Initial use of subcutaneous plasma-derived C1 inhibitor in prophylaxis of acute attacks of hereditary angioedema in pregnant patients in Slovakia. Vnitřní lékařství. 69(4). 265–268. 1 indexed citations
8.
Bobčáková, Anna, et al.. (2023). The use of ketotifen as long-term anti-inflammatory prophylaxis in children with PFAPA syndrome. Frontiers in Immunology. 14. 1302875–1302875. 5 indexed citations
9.
Jeseňák, Miloš, Zuzana Diamant, Dagmar Simon, et al.. (2023). Eosinophils—from cradle to grave. Allergy. 78(12). 3077–3102. 16 indexed citations
10.
Roth‐Walter, Franziska, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.. (2023). Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology. Allergy. 79(5). 1089–1122. 15 indexed citations
11.
Střı́ž, Ilja, Korneliusz Golebski, Zuzana Střížová, et al.. (2023). New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clinical Science. 137(9). 727–753. 22 indexed citations
12.
13.
14.
Valerieva, Anna, Maria Staevska, Vesna Grivcheva‐Panovska, et al.. (2021). Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry. World Allergy Organization Journal. 14(4). 100535–100535. 7 indexed citations
15.
Jeseňák, Miloš, et al.. (2020). What is hiden behind autoinflammation?. Vnitřní lékařství. 66(3). e13–e21.
16.
Papi, Alberto, С. Н. Авдеев, Peter M.A. Calverley, et al.. (2020). Use of mucolytics in COPD: A Delphi consensus study. Respiratory Medicine. 175. 106190–106190. 8 indexed citations
17.
Jeseňák, Miloš, et al.. (2018). Canakinumab as monotherapy for treatment of familial Mediterranean fever – first report in Central and Eastern Europe region. Bratislavské lekárske listy/Bratislava medical journal. 119(4). 198–200. 10 indexed citations
18.
Zeman, Krzysztof, et al.. (2017). Preventive effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections-open-labelprospective study.. Current Pediatric Research. 21(1). 99–104. 6 indexed citations
19.
Babušíková, Eva, Miloš Jeseňák, Peter Ďurdík, Dušan Dobrota, & Peter Bánovčin. (2008). Exhaled carbon monoxide as a new marker of respiratory diseases in children.. PubMed. 59 Suppl 6. 9–17. 32 indexed citations
20.
Ronchetti, R, Moniek Zuurbier, Miloš Jeseňák, et al.. (2006). Children's health and mercury exposure. Acta Paediatrica. 95(s453). 36–44. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Polte Breakdown of academic impact, for papers by Roberto Silva Costa Breakdown of academic impact, for papers by Ivana Čepelak Breakdown of academic impact, for papers by Suck Chei Choi Breakdown of academic impact, for papers by Antônio Carlos Seguro Breakdown of academic impact, for papers by Mohammad Najafi Breakdown of academic impact, for papers by Junpeng Wang Breakdown of academic impact, for papers by Wim Calame Breakdown of academic impact, for papers by Lúcia Andrade Breakdown of academic impact, for papers by David Lamb
Rankless by CCL
2026